ELEVANCE HEALTH, INC. Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net
ELEVANCE HEALTH, INC. (ELV) reported Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net of $57.00 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-04-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet · last filed 2020-04-29
- ELEVANCE HEALTH, INC. other than temporary impairment losses, investments, portion recognized in earnings, net for the quarter ending 2020-03-31 was $57.00M, a 470.00% increase year-over-year.
- ELEVANCE HEALTH, INC. other than temporary impairment losses, investments, portion recognized in earnings, net for the quarter ending 2019-12-31 was $17.00M, a 112.50% increase year-over-year.
- ELEVANCE HEALTH, INC. other than temporary impairment losses, investments, portion recognized in earnings, net for the quarter ending 2019-09-30 was $13.00M, a 116.67% increase year-over-year.
- ELEVANCE HEALTH, INC. other than temporary impairment losses, investments, portion recognized in earnings, net for the quarter ending 2019-06-30 was $7.00M, a 75.00% increase year-over-year.
- ELEVANCE HEALTH, INC. other than temporary impairment losses, investments, portion recognized in earnings, net for fiscal 2019 was $47.00M, a 80.77% increase from fiscal 2018.
- ELEVANCE HEALTH, INC. other than temporary impairment losses, investments, portion recognized in earnings, net for fiscal 2018 was $26.00M, a 21.21% decline from fiscal 2017.
- ELEVANCE HEALTH, INC. other than temporary impairment losses, investments, portion recognized in earnings, net for fiscal 2017 was $33.00M, a 71.30% decline from fiscal 2016.
- ELEVANCE HEALTH, INC. other than temporary impairment losses, investments, portion recognized in earnings, net for fiscal 2016 was $115.00M, a 37.89% increase from fiscal 2015.
| Period end | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 3 month | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 3 month as first filed | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 6 month | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 6 month as first filed | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 9 month | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 9 month as first filed | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 12 month | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | $57.00M 10-Q · filed 2020-04-29 | $74.00M derived: sum of 2 quarters · filed 2020-04-29 | $87.00M derived: sum of 3 quarters · filed 2020-04-29 | $94.00M derived: sum of 4 quarters · filed 2020-04-29 | ||||
| 2019-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $30.00M derived: sum of 2 quarters · filed 2020-02-19 | $37.00M derived: sum of 3 quarters · filed 2020-02-19 | $47.00M 10-K · filed 2020-02-19 | ||||
| 2019-09-30 | $13.00M 10-Q · filed 2019-10-23 | $20.00M derived: sum of 2 quarters · filed 2019-10-23 | $30.00M 10-Q · filed 2019-10-23 | $38.00M derived: sum of 4 quarters · filed 2020-04-29 | ||||
| 2019-06-30 | $7.00M 10-Q · filed 2019-07-24 | $17.00M 10-Q · filed 2019-07-24 | $25.00M derived: sum of 3 quarters · filed 2020-04-29 | $31.00M derived: sum of 4 quarters · filed 2020-04-29 | ||||
| 2019-03-31 | $10.00M 10-Q · filed 2020-04-29 | $18.00M derived: sum of 2 quarters · filed 2020-04-29 | $24.00M derived: sum of 3 quarters · filed 2020-04-29 | $28.00M derived: sum of 4 quarters · filed 2020-04-29 | ||||
| 2018-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $14.00M derived: sum of 2 quarters · filed 2020-02-19 | $18.00M derived: sum of 3 quarters · filed 2020-02-19 | $26.00M 10-K · filed 2020-02-19 | ||||
| 2018-09-30 | $6.00M 10-Q · filed 2019-10-23 | $10.00M derived: sum of 2 quarters · filed 2019-10-23 | $18.00M 10-Q · filed 2019-10-23 | $30.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $4.00M 10-Q · filed 2019-07-24 | $4.40M 10-Q · filed 2018-07-25 | $12.00M 10-Q · filed 2019-07-24 | $12.30M 10-Q · filed 2018-07-25 | $24.00M derived: sum of 3 quarters · filed 2020-02-19 | $30.00M derived: sum of 4 quarters · filed 2020-02-19 | ||
| 2018-03-31 | $8.00M 10-Q · filed 2019-04-24 | $7.90M 10-Q · filed 2018-04-25 | $20.00M derived: sum of 2 quarters · filed 2020-02-19 | $26.00M derived: sum of 3 quarters · filed 2020-02-19 | $33.20M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2017-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $18.00M derived: sum of 2 quarters · filed 2020-02-19 | $25.20M derived: sum of 3 quarters · filed 2020-02-19 | $33.00M 10-K · filed 2020-02-19 | $33.10M 10-K · filed 2018-02-21 | |||
| 2017-09-30 | $6.00M 10-Q · filed 2018-10-31 | $5.60M 10-Q · filed 2017-10-25 | $13.20M derived: sum of 2 quarters · filed 2018-10-31 | $21.00M 10-Q · filed 2018-10-31 | $20.90M 10-Q · filed 2017-10-25 | $32.70M derived: sum of 4 quarters · filed 2019-02-20 | ||
| 2017-06-30 | $7.20M 10-Q · filed 2018-07-25 | $15.30M 10-Q · filed 2018-07-25 | $26.70M derived: sum of 3 quarters · filed 2019-02-20 | $37.70M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $8.10M 10-Q · filed 2018-04-25 | $19.50M derived: sum of 2 quarters · filed 2019-02-20 | $30.50M derived: sum of 3 quarters · filed 2019-02-20 | $56.20M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $11.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $22.40M derived: sum of 2 quarters · filed 2019-02-20 | $48.10M derived: sum of 3 quarters · filed 2019-02-20 | $115.00M 10-K · filed 2019-02-20 | $115.40M 10-K · filed 2017-02-22 | |||
| 2016-09-30 | $11.00M 10-Q · filed 2017-10-25 | $36.70M derived: sum of 2 quarters · filed 2017-10-25 | $103.60M 10-Q · filed 2017-10-25 | $132.10M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-06-30 | $25.70M 10-Q · filed 2017-07-26 | $92.60M 10-Q · filed 2017-07-26 | $121.10M derived: sum of 3 quarters · filed 2018-02-21 | $140.20M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-03-31 | $66.90M 10-Q · filed 2017-04-26 | $95.40M derived: sum of 2 quarters · filed 2018-02-21 | $114.50M derived: sum of 3 quarters · filed 2018-02-21 | $136.30M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2015-12-31 | $28.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $47.60M derived: sum of 2 quarters · filed 2018-02-21 | $69.40M derived: sum of 3 quarters · filed 2018-02-21 | $83.40M 10-K · filed 2018-02-21 | ||||
| 2015-09-30 | $19.10M 10-Q · filed 2016-11-02 | $40.90M derived: sum of 2 quarters · filed 2016-11-02 | $54.90M 10-Q · filed 2016-11-02 | $68.40M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-06-30 | $21.80M 10-Q · filed 2016-07-27 | $35.80M 10-Q · filed 2016-07-27 | $49.30M derived: sum of 3 quarters · filed 2017-02-22 | $63.10M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-03-31 | $14.00M 10-Q · filed 2016-04-27 | $27.50M derived: sum of 2 quarters · filed 2017-02-22 | $41.30M derived: sum of 3 quarters · filed 2017-02-22 | $52.20M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2014-12-31 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $27.30M derived: sum of 2 quarters · filed 2017-02-22 | $38.20M derived: sum of 3 quarters · filed 2017-02-22 | $49.00M 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | $13.80M 10-Q · filed 2015-10-28 | $24.70M derived: sum of 2 quarters · filed 2015-10-28 | $35.50M 10-Q · filed 2015-10-28 | $61.30M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $10.90M 10-Q · filed 2015-07-29 | $21.70M 10-Q · filed 2015-07-29 | $47.50M derived: sum of 3 quarters · filed 2016-02-19 | $73.70M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $10.80M 10-Q · filed 2015-04-29 | $36.60M derived: sum of 2 quarters · filed 2016-02-19 | $62.80M derived: sum of 3 quarters · filed 2016-02-19 | $71.80M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $25.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $52.00M derived: sum of 2 quarters · filed 2016-02-19 | $61.00M derived: sum of 3 quarters · filed 2016-02-19 | $98.90M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $26.20M 10-Q · filed 2014-10-29 | $35.20M derived: sum of 2 quarters · filed 2014-10-29 | $73.10M 10-Q · filed 2014-10-29 | $90.30M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $9.00M 10-Q · filed 2014-07-30 | $46.90M 10-Q · filed 2013-07-24 | $64.10M derived: sum of 3 quarters · filed 2015-02-24 | $67.90M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $37.90M 10-Q · filed 2014-04-30 | $55.10M derived: sum of 2 quarters · filed 2015-02-24 | $58.90M derived: sum of 3 quarters · filed 2015-02-24 | $64.80M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $17.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $21.00M derived: sum of 2 quarters · filed 2015-02-24 | $26.90M derived: sum of 3 quarters · filed 2015-02-24 | $37.80M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $3.80M 10-Q · filed 2013-10-23 | $9.70M derived: sum of 2 quarters · filed 2013-10-23 | $20.60M 10-Q · filed 2013-10-23 | $80.20M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2012-06-30 | $5.90M 10-Q · filed 2013-07-24 | $16.80M 10-Q · filed 2013-07-24 | $76.40M derived: sum of 3 quarters · filed 2014-02-20 | $99.30M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2012-03-31 | $10.90M 10-Q · filed 2013-04-24 | $70.50M derived: sum of 2 quarters · filed 2014-02-20 | $93.40M derived: sum of 3 quarters · filed 2014-02-20 | $101.80M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2011-12-31 | $59.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $82.50M derived: sum of 2 quarters · filed 2014-02-20 | $90.90M derived: sum of 3 quarters · filed 2014-02-20 | $93.30M 10-K · filed 2014-02-20 | ||||
| 2011-09-30 | $22.90M 10-Q · filed 2012-11-07 | $31.30M derived: sum of 2 quarters · filed 2012-11-07 | $33.70M 10-Q · filed 2012-11-07 | $44.10M derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-06-30 | $8.40M 10-Q · filed 2012-07-25 | $10.80M 10-Q · filed 2012-07-25 | $21.20M derived: sum of 3 quarters · filed 2013-02-22 | $24.40M derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-03-31 | $2.40M 10-Q · filed 2012-04-25 | $12.80M derived: sum of 2 quarters · filed 2013-02-22 | $16.00M derived: sum of 3 quarters · filed 2013-02-22 | $22.10M derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2010-12-31 | $10.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $13.60M derived: sum of 2 quarters · filed 2013-02-22 | $19.70M derived: sum of 3 quarters · filed 2013-02-22 | $39.40M 10-K · filed 2013-02-22 | ||||
| 2010-09-30 | $3.20M 10-Q · filed 2011-10-26 | $9.30M derived: sum of 2 quarters · filed 2011-10-26 | $29.00M 10-Q · filed 2011-10-26 | |||||
| 2010-06-30 | $6.10M 10-Q · filed 2011-07-27 | $25.80M 10-Q · filed 2011-07-27 | ||||||
| 2009-12-31 | $450.20M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |